Care coordination/management for adults with Type 1 diabetes
Around 3.2 million people in the UK have been diagnosed with diabetes. Of these, approximately 300,000 have Type 1 diabetes.
Risk of diabetic ketoacidosis associated with the use of sodium-glucose cotransporter-2 inhibitors
Diabetic Ketoacidosis (DKA) has been reported in patients with diabetes taking SGLT-2 inhibitor drugs both in clinical trials and in real life situations, particularly amongst patients taking insulin.
Standards of care for management of adults with type 1 diabetes 2017
The 2020 update of Standards of care for management of adults with type 1 diabetes is now available.
ABCD believes that while care for those with type 1 diabetes may take place in different settings, that care should be of a universally high standard, and should explicitly involve access to consultant-led specialist teams, experienced in the management of type 1 diabetes.
Clinical Practice Guidelines for Management of Lipids in Adults with Diabetes Mellitus and Nephropathy and/or Chronic Kidney Disease
Cardiovascular disease is a key contributor to excess morbidity and premature mortality in diabetes and chronic kidney disease is an independent and major risk factor for cardiovascular disease. Lipids are a modifiable risk factor and good lipid management offers improved outcomes for diabetic patients with concomitant renal disease. This report provides a detailed rationale in association with the guidelines, as well as recommendations for clinical audit and outstanding questions for further research.
Hypertension, RAA blockade in diabetes and kidney disease
A significant percentage of patients with diabetes develop chronic kidney disease (CKD), and diabetes is also a leading cause of end-stage renal disease. More than a quarter of patients who are on dialysis in the UK have diabetes. Diabetic kidney disease is associated with high morbidity and mortality, which are predominantly related to cardiovascular complications and the progression of kidney disease that requires renal replacement therapy. Hypertension is a modifiable risk factor for cardiovascular complications and progression of CKD.3
New ABCD honorary treasurer
After canvassing the membership interest from four excellent candidates was expressed and an election was held. I am delighted to announce that Dr Andy Macklin was successfully elected and will be shadowing Tony Robinson, our current treasurer, for the next few months before taking over in the spring.
Our sincere thanks go to Dr Tony Robinson for all his hard work, dedication and pragmatism, following a very successful 4 years in post.
Final reminder and joining instructions for the Type 1 Collaborative Webinar
Joining Instructions to see this important webinar on
“FLASH GLUCOSE MONITORING & CONTINUOUS GLUCOSE MONITORING”
Tuesday 27th February 2018
5.00 – 6.00pm
Agenda & speakers;
Type 1 Collaborative Webinar
A must see webinar on: "Flash Glucose Monitoring & Continuous Glucose Monitoring"
Tuesday 27th February 5.00 – 6.00pm
Agenda & Speakers:
News from the APPG for Diabetes
APPG for Diabetes Meeting on the Childhood Obesity PlanA meeting of the All-Party Parliamentary Group for Diabetes took place to discuss where the current Childhood Obesity Strategy has been effective and also ineffective. Speakers included were: 
Search the Association of British Clinical Diabetologists |